1. Home
  2. EVO vs AHCO Comparison

EVO vs AHCO Comparison

Compare EVO & AHCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVO
  • AHCO
  • Stock Information
  • Founded
  • EVO 1993
  • AHCO N/A
  • Country
  • EVO Germany
  • AHCO United States
  • Employees
  • EVO N/A
  • AHCO N/A
  • Industry
  • EVO Biotechnology: Pharmaceutical Preparations
  • AHCO Medical/Nursing Services
  • Sector
  • EVO Health Care
  • AHCO Health Care
  • Exchange
  • EVO Nasdaq
  • AHCO Nasdaq
  • Market Cap
  • EVO 1.6B
  • AHCO 1.3B
  • IPO Year
  • EVO 2021
  • AHCO N/A
  • Fundamental
  • Price
  • EVO $4.50
  • AHCO $9.77
  • Analyst Decision
  • EVO Buy
  • AHCO Strong Buy
  • Analyst Count
  • EVO 2
  • AHCO 5
  • Target Price
  • EVO $5.90
  • AHCO $12.40
  • AVG Volume (30 Days)
  • EVO 152.3K
  • AHCO 891.1K
  • Earning Date
  • EVO 11-06-2024
  • AHCO 11-05-2024
  • Dividend Yield
  • EVO N/A
  • AHCO N/A
  • EPS Growth
  • EVO N/A
  • AHCO N/A
  • EPS
  • EVO N/A
  • AHCO N/A
  • Revenue
  • EVO $866,665,179.00
  • AHCO $3,262,564,000.00
  • Revenue This Year
  • EVO $4.56
  • AHCO $3.06
  • Revenue Next Year
  • EVO $13.44
  • AHCO $2.91
  • P/E Ratio
  • EVO N/A
  • AHCO N/A
  • Revenue Growth
  • EVO N/A
  • AHCO 4.49
  • 52 Week Low
  • EVO $2.85
  • AHCO $6.43
  • 52 Week High
  • EVO $12.00
  • AHCO $11.90
  • Technical
  • Relative Strength Index (RSI)
  • EVO 49.65
  • AHCO 52.92
  • Support Level
  • EVO $4.39
  • AHCO $9.09
  • Resistance Level
  • EVO $4.81
  • AHCO $10.33
  • Average True Range (ATR)
  • EVO 0.13
  • AHCO 0.42
  • MACD
  • EVO -0.05
  • AHCO 0.06
  • Stochastic Oscillator
  • EVO 45.24
  • AHCO 76.61

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About AHCO AdaptHealth Corp.

AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. It focuses on providing; sleep therapy equipment, supplies, and related services (including CPAP and bi-PAP services) to individuals suffering from obstructive sleep apnea (OSA), medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors (CGM and insulin pumps), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs.

Share on Social Networks: